Adrian is a 25-year veteran of the biotech industry. Adrian is President and CEO of Oxford Gene Technology (OGT), a biotechnology company focussed on diagnosing cancer and rare disease. OGT has several factories and offices in the UK and US. Adrian also sits on the board of DRW a Cambridge UK based company focused on combatting respiratory and other infectious diseases around the world. Prior to joining OGT Adrian was UK MD of Hologic a global med tech company. Previously he was responsible for the cancer screening business at Qiagen, and the personalised medicine business at Roche.